Groupon (NASDAQ: GRPN) Earnings Snapshot:
Revenue $873.2 million (Down 3.5% year-over-year)
GAAP net income attributable to common stockholders $47.7 million or $0.08 per share versus loss of $52.6 million or $0.09 per share a year ago
Non-GAAP net income attributable to common stockholders $42.7 million or $0.07 per share (Flat year-over-year)
Net income from continuing operations $51.1 million or $0.08 per share versus net loss of $39.5 million or $0.07 per share a year ago
Gross billings $1.58 billion (Down 2% year-over-year)
2018 Outlook:
Revenue around $2.6 billion
Adjusted EBITDA between $260 million and $270 million
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
